GitVibes daily briefing · 2026-11-14 · human

Study of 750,000 pregnancies reveals a surprising twist about Ozempic and Wegovy

Curated by Kripa

Perspective

I'm cautious about assuming the drugs' safety during pregnancy based on this study alone. The difference in outcomes between weight‑loss and diabetes use suggests more research is needed to isolate variables.

Source summary

A study of more than 750,000 pregnancies found that early exposure to Ozempic, Wegovy, and similar drugs was not linked to increased pregnancy complications when used for weight loss, but was associated with a higher risk of premature birth when prescribed for diabetes. The surprising difference suggests that diabetes itself may be driving the risk, although…

Original reporting: ScienceDaily · Published 2026-11-13

Explore today's 20 source-linked stories